$CCEP

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) said it bought back shares from 3 to 7 Aug 2026 under its Feb 17, 2026 buyback program. It repurchased 210,000 ordinary shares on US trading venues and 84,868 on London venues, with prices ranging from USD 102.67 to 110.70 and GBP 76.40 to 82.25. Shares will be cancelled; up to EUR 1 billion expected.

Original reporting
Published Aug 10, 2026, 3:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 3:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transactions in Own Shares — source image
Decision brief

The 30-second read

$CCEPBullishLow
01

Why it matters

The article provides transaction-level buyback quantities and price ranges across US and London trading venues, but no new financial targets or operational developments.

02

Market read

Traders may treat this as incremental confirmation of buyback pace and execution, but it is unlikely to drive a major repricing without additional guidance or a change in authorization size.

03

What to watch

The announcement does not state total remaining authorization usage, average repurchase cost versus prior tranches, or whether repurchases were opportunistic versus defensive.

Relevance 4/10Novelty 4/10Timing: buyback execution disclosed for 3-7 Aug 2026, published 10 Aug 2026

Background

CCEP confirms share repurchases under its 17 Feb 2026 buyback programme, with shares to be cancelled.

Company-level read

Ticker impact

$CCEPBullishMedium confidence
Context

CCEP reports it bought back 210,000 ordinary shares on US trading venues and 84,868 on London venues, to be cancelled.

Expected impact

Small, short-lived positive bias; no clear catalyst beyond ongoing buyback program.

Evidence & confidence

The disclosure is specific to completed repurchases (3-7 Aug 2026) under an already-announced EUR 1 billion buyback program, without new guidance, financing, or operational changes.

Market effects

Consumer staples buyback activity can marginally support sector sentiment, but this is company-specific execution rather than a sector shock.

Limited impact expected for Europe equities beyond CCEP, since the trades are part of an ongoing program.

Low global relevance; buyback execution does not change cross-border demand or macro drivers.

Counterpoint

Buybacks can be offset by ongoing dilution or cash-flow constraints; without net buyback pace versus issuance, the price impact may be negligible.

Key entities

  • Coca-Cola Europacific Partners

    Subject of the buyback execution disclosure; repurchased ordinary shares to be cancelled.

  • Goldman Sachs

    Broker/venue counterparty referenced as the source for the repurchases on both US and London trading venues.

Related articles

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.